is tirzepatide on the fda shortage list Lilly's weight-loss drug removed from FDA's Tirzepatide No Longer in Shortage:

A discussion on patient perspectives about weight change is based on key preclinical and clinical trials, meta-analyses, and reviews and is supplemented by the authors clinical judgment and research experience in the field

No research-use label or wording that hints at human use

This can also help prevent dry skin and respiratory issues that can occur in dry environments

Allergic reactions: Symptoms of an allergic reaction include swelling of the face, lips, tongue, or throat

This accelerated approach carries a 15-20% higher side effect burden compared to standard titration, primarily during weeks 3-8 when dosing advancement overlaps with peak GI symptoms